Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: early results

BACKGROUND: There is growing evidence that prostate cancer (PC) cells are more sensitive to high fraction dose in hypofractionation schemes. High-dose-rate (HDR) brachytherapy as monotherapy is established to be a good treatment option for PC using extremely hypofractionated schemes. This hypofracti...

Descripción completa

Detalles Bibliográficos
Autores principales: Aluwini, Shafak, van Rooij, Peter, Hoogeman, Mischa, Kirkels, Wim, Kolkman-Deurloo, Inger-Karine, Bangma, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641975/
https://www.ncbi.nlm.nih.gov/pubmed/23570391
http://dx.doi.org/10.1186/1748-717X-8-84

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641975/
https://www.ncbi.nlm.nih.gov/pubmed/23570391
http://dx.doi.org/10.1186/1748-717X-8-84

Ejemplares similares